Trial Details
TERMINATEDBasic Information
| Clinical ID | c727 |
|---|---|
| Identifier | NCT03800420 |
| Trial Title | Efficacy and Safety of BBT-401-1S in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: BBT-401-1S first and then Placebo|DRUG: Placebo first and then BBT-401-1S |
Participant Information
| Sponsor | Bridge Biotherapeutics, Inc. |
|---|---|
| City | Sacramento |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-04-22 |
|---|---|
| Primary Completion Date | 2020-05-18 |
| Completion Date | 2020-07-31 |